All stock lists
Xponential Fitness, Inc. (XPOF)
United States · Delayed Price · Currency is USD
Services-Miscellaneous Amusement & Recreation
4.17-0.03 (-0.60%)
Insider Score
––Not scored
XPOF Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
XPOF analyst forecast
XPOF analyst consensus
Hold4 ratings
Buy 0 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
XPOF 12-month price target
$4.50+9.2% upsideaverage of 1 firm
$4.50High
$4.50Low
Best analysts covering XPOF
- Guggenheim14%success rate · 7 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
XPOF analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | Neutral | $4.50 | +17.5% | Reiterated | 2026-09-16 | |
| — | Roth Capital | Neutral | — | — | Reiterated | 2026-08-10 |
| — | B. Riley Securities | Neutral | — | — | Reiterated | 2026-08-10 |
| — | Guggenheim | Neutral | — | — | Downgraded | 2026-08-07 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2026-03-19 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-03-02 |
| — | Baird | Neutral | — | — | Reiterated | 2026-02-27 |
| — | Stifel | Hold | — | — | Reiterated | 2025-11-21 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-11-10 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2025-08-08 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-12 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2025-05-09 |
| — | Lake Street | Buy | — | — | Reiterated | 2025-03-14 |
| — | B. Riley Securities | Neutral | — | — | Reiterated | 2025-03-14 |
| — | Stifel | Hold | — | — | Downgraded | 2025-03-14 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-03-14 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-01-06 |
| — | Stifel | Buy | — | — | Reiterated | 2024-11-11 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2024-11-08 |
| — | B. Riley Securities | Neutral | — | — | Reiterated | 2024-08-05 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2024-08-02 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-08-02 |
| — | Baird | Neutral | — | — | Reiterated | 2024-08-02 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2024-08-02 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2024-07-11 |
| — | Guggenheim | Buy | — | — | Reiterated | 2024-06-18 |
| — | B. Riley Securities | Neutral | — | — | Downgraded | 2024-05-13 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2024-05-13 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2024-05-03 |
| — | Stifel | Buy | — | — | Reiterated | 2024-04-12 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2024-03-13 |
| — | Stifel | Buy | — | — | Reiterated | 2024-03-05 |
| — | Citigroup | Buy | — | — | Reiterated | 2024-03-04 |
| — | Baird | Neutral | — | — | Reiterated | 2024-03-01 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2024-01-03 |
| — | Stifel | Buy | — | — | Upgraded | 2023-12-13 |
| — | Guggenheim | Buy | — | — | Reiterated | 2023-11-15 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-11-08 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2023-11-01 |
| — | Guggenheim | Buy | — | — | Reiterated | 2023-09-15 |
| — | Guggenheim | Buy | — | — | Reiterated | 2023-08-16 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-08-04 |
| — | Baird | Neutral | — | — | Reiterated | 2023-06-28 |
| — | Roth MKM | Buy | — | — | Reiterated | 2023-06-28 |
| — | Raymond James | Buy | — | — | Downgraded | 2023-06-27 |
| — | Baird | Neutral | — | — | Reiterated | 2023-06-27 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-06-08 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-05-08 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-05-08 |
| — | Guggenheim | Buy | — | — | Reiterated | 2023-05-08 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-05-05 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-05-05 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2023-04-26 |
| — | Lake Street | Buy | — | — | Reiterated | 2023-04-10 |
| — | Baird | Neutral | — | — | Downgraded | 2023-04-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2023-03-13 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-03-06 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-03-03 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-03-03 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-02-15 |
XPOF earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | -0.03 | -0.91 | $73.4M | $83.0M |
| 2026-05-07 | 0.11 | -0.04 | $63.8M | $60.7M |
| 2026-08-06 | 0.13 | 0.02 | $64.4M | $66.0M |
| 2026-11-05 | 0.12 | 0.00 | $63.0M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.